In Unanimous Decision, Fed Appeals Court Reverses Lower Court Ruling and Allows 340B Antitrust Lawsuit Against Insulin Drugmakers to Advance

The U.S. 2nd Circuit Court of Appeals' 3-0 decision reversed a lower court’s 2024 ruling that had denied health centers' antitrust claims against four drug manufacturers that have placed contract pharmacy restrictions.
A federal appeals court ruled unanimously Wednesday that an antitrust class action lawsuit, in which two health clinics alleged four [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Touts 340B Rebate Pilot Proposal to Appeals Court, Hospitals File Amicus Brief Urging Court to Reject Rebates

HHS highlighted its proposed 340B rebate pilot in an Aug. 1 brief filed with the U.S. Court of Appeals for the District of Columbia Circuit.
The U.S. Department of Health and Human Services (HHS) touted the agency’s recently announced plan to pilot a 340B rebate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Judge Rejects HHS’ Partial Motion to Dismiss in Drugmakers’ Lawsuit Challenging STD Site Recertifications

The U.S. District Court for the District of Columbia, denied HHS’ partial motion to dismiss drugmakers’ claims in a lawsuit alleging that the federal government allowed certain STD clinics to unlawfully participate in the 340B program.
A Washington D.C. federal court this week rejected the Department of Health and Human Services’ (HHS) request to partially dismiss [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump Calls on Drugmakers to Implement ‘Most Favored Nation’ Pricing, Resurrects Idea to Extend MFN to all Medicaid Patients

President Donald Trump sent a July 31 letter to 17 major drugmakers to begin implementing his proposed “most-favored nation” model for prescription drugs.
President Donald Trump is urging more than a dozen leading pharmaceutical manufacturers to begin implementing his proposed “most-favored nation” (MFN) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate HELP Committee Chairman Again Criticizes 340B Hospitals and Calls for Reforms at Hearing

Senate HELP Committee Chairman Bill Cassidy (R-La.) pointed to 340B program reforms as one potential way to address health care costs at a July 31 hearing.
A key Senate Republican and outspoken 340B critic recently argued that any comprehensive efforts to address healthcare affordability in Congress [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Liquidia Tightens 340B Contract Pharmacy Restrictions; Biogen, Sanofi Exempt New States

Liquidia announced that as of Aug. 1, it will only ship 340B purchases of Yutrepia to covered entities with a contract pharmacy in its limited distribution network.
A North Carolina-based drugmaker recently tightened its 340B contract pharmacy restrictions to limit distribution of a pulmonary arterial hypertension treatment—just [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

340B Providers, Drug Industry Raise Concerns Over HRSA’s 340B Rebate Model Pilot Proposal 

340B provider groups and drugmakers raised concerns Thursday over HRSA's proposed 340B rebate guidance.
340B covered entities and drugmakers offered competing criticisms Thursday of the Health Resources and Services Administration’s (HRSA) newly released 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health Survey: Most Hospitals Would Struggle to Stay Open, Maintain Care Levels Under 340B Rebate Model

340B Health surveyed hundreds of its member hospitals on the likely effects of drugmakers' proposed 340B rebate models.
A majority of 340B hospitals surveyed said the costs associated with implementing drugmakers’ proposed rebate models would hinder their ability [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Dark Money Group’s Survey Claims GOP Primary Voters Oppose State Contract Pharmacy Access Laws

Dark money group Building America’s Future said it surveyed more than 1,000 likely GOP primary voters on their support for “expanding” the 340B program by states passing contract pharmacy access bills.
The dark money group behind a campaign targeting GOP-led states’ recent efforts to enact 340B contract pharmacy access laws released [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Alkermes, Novartis Exempt Additional States from 340B Contract Pharmacy Restrictions

Alkermes is one of two drugmakers to recently announce new state exemptions to their 340B contract pharmacy restrictions.
Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live